Gene expression characteristics of breast cancer stem cells

被引:0
作者
Dogan, Sait Murat [1 ]
Ercetin, Ayse Pinar [1 ]
Altun, Zekiye [1 ]
Dursun, Duygu [1 ]
Aktas, Safiye [1 ]
机构
[1] Dokuz Eylul Univ, Inst Oncol, Dept Basic Oncol, Izmir, Turkey
来源
JOURNAL OF BUON | 2015年 / 20卷 / 05期
关键词
breast cancer; cancer initiating cell; cancer stem cell; gene expression; PROTEIN; IDENTIFICATION; OVEREXPRESSION; METHYLATION; METASTASIS; INHIBITOR; INVASION; P21;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Breast cancer stem cells have been found to be responsible for tumorigenic potential and resistance to therapy. This study aimed at comparing gene expression profiles in breast cancer, based on the differences of stem cells in their biological characteristics. Methods: Four breast cancer cell lines with different molecular and biological characteristics were used to analyze 84 breast cancer-related gene expressions. These were the ductal human epithelial breast cancer cell line T47D (HTB-133) with metastatic origin, the invasive ductal human breast carcinoma cell line MDA-MB-231 (HTB-26), the ductal human epithelial breast cancer cell line BT-474 (HTB-20) and the human metastatic breast adenocarcinoma cell line MCF-7 (HTB-22). Results: There were significant differences between the breast cancer cells and the stem cells, particularly in angigenesis, migration, proliferation and the expression of the DNA repair genes. Conclusion: These data indicated the absence of a general cancer stem cell in breast cancer. Our study supports the use of the term "breast cancer initiating cells" instead of breast cancer stem cells. All of these genetic differences should be taken into account in the planning of final therapeutic approach.
引用
收藏
页码:1304 / 1313
页数:10
相关论文
共 50 条
  • [41] Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel
    Izawa, Yuki
    Kashii-Magaribuchi, Karin
    Yoshida, Kana
    Nosaka, Mayu
    Tsuji, Nanami
    Yamamoto, Ai
    Kuroyanagi, Kana
    Tono, Kanoko
    Tanihata, Misato
    Imanishi, Moe
    Onishi, Momoka
    Sakiyama, Mayu
    Inoue, Sana
    Takahashi, Rei
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2018, 51 (06) : 173 - 183
  • [42] Cancer stem cell in breast cancer therapeutic resistance
    Bai, Xupeng
    Ni, Jie
    Beretov, Julia
    Graham, Peter
    Li, Yong
    CANCER TREATMENT REVIEWS, 2018, 69 : 152 - 163
  • [43] Dual Epigenetic Regulation of ER36 Expression in Breast Cancer Cells
    Thiebaut, Charlene
    Chesnel, Amand
    Merlin, Jean-Louis
    Chesnel, Maelle
    Leroux, Agnes
    Harle, Alexandre
    Dumond, Helene
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (11)
  • [44] Breast cancer stem cells: Reply
    Polyak, Kornelia
    STEM CELL REVIEWS, 2007, 3 (02): : 113 - 113
  • [45] Tumour Stem Cells in Breast Cancer
    Ibragimova, Marina
    Tsyganov, Matvey
    Litviakov, Nikolai
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (09)
  • [46] Cancer Stem Cells Stemness Transcription Factors Expression Correlates with Breast Cancer Disease Stage
    Apostolou, Panagiotis
    Toloudi, Maria
    Chatziioannou, Marina
    Ioannou, Eleni
    Papasotiriou, Ioannis
    CURRENT STEM CELL RESEARCH & THERAPY, 2012, 7 (06) : 415 - 419
  • [47] Knockdown of Ran GTPase expression inhibits the proliferation and migration of breast cancer cells
    Sheng, Chenyi
    Qiu, Jian
    Wang, Yingying
    Lie, Zhixian
    Wang, Hua
    Wang, Qingqing
    Huang, Yeqing
    Zhu, Lianxin
    Shi, Feng
    Chen, Yingying
    Xiong, Shiyao
    Xu, Zhen
    Ni, Qichao
    MOLECULAR MEDICINE REPORTS, 2018, 18 (01) : 157 - 168
  • [48] MicroRNAs in breast cancer and breast cancer stem cells and their potential for breast cancer therapy
    Li Jia
    Shen Lei
    Xiao Xi-gang
    Fang Lin
    CHINESE MEDICAL JOURNAL, 2013, 126 (13) : 2556 - 2563
  • [49] Estrogen-Related Receptors Gene Expression and Copy Number Alteration Association With the Clinicopathologic Characteristics of Breast Cancer
    Shatnawi, Aymen
    Ayoub, Nehad M.
    Alkhalifa, Amer E.
    Ibrahim, Dalia R.
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2022, 16
  • [50] Rab31 expression levels modulate tumor-relevant characteristics of breast cancer cells
    Grismayer, Bettina
    Soelch, Susanne
    Seubert, Bastian
    Kirchner, Thomas
    Schaefer, Sonja
    Baretton, Gustavo
    Schmitt, Manfred
    Luther, Thomas
    Krueger, Achim
    Kotzsch, Matthias
    Magdolen, Viktor
    MOLECULAR CANCER, 2012, 11